CDC73 and parathyroid gland carcinoma: As HPT-JT patients carry germline CDC73 gene mutations or deletions, it comes as no surprise that the prevalence of parathyroid carcinoma in this patient category is much higher (15–30%) than in unselected PHPT patient cohorts (< 1%).